Patents by Inventor Yi Ao

Yi Ao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Earphone
    Patent number: 11968492
    Abstract: Described herein is an earphone including an ear hook portion and an earphone portion, the ear hook portion is provided with a first magnetic attraction member, the earphone portion is provided with a second magnetic attraction member, and the second magnetic attraction member attracts and cooperates with the first magnetic attraction member to connect the earphone portion with the ear hook portion; a heart rate detection module, the heart rate detection module is arranged on the ear hook portion and/or earphone portion.
    Type: Grant
    Filed: May 19, 2022
    Date of Patent: April 23, 2024
    Assignee: Anhui Huami Information Technology Co., Ltd.
    Inventors: Yi Zhang, Dong Ao, Qi An
  • Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
    Patent number: 11839683
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: December 12, 2023
    Assignee: Emergex USA Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • METHOD OF RAPIDLY ACHIEVING THERAPEUTIC CONCENTRATIONS OF TRIPTANS FOR TREATMENT OF MIGRAINES AND CLUSTER HEADACHES
    Publication number: 20230255881
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: April 21, 2023
    Publication date: August 17, 2023
    Inventors: Mahmoud Ameri, Donald Kellerman, Yi Ao
  • Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
    Patent number: 11660264
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: May 30, 2023
    Assignee: Emergex USA Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Yi Ao
  • Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
    Patent number: 11660265
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods for treating migraine by administering zolmitriptan using an adhesive dermally-applied microarray (ADAM) resulting in rapid and durable pain relief, pain freedom and reduction in most bothersome migraine-associated symptoms (MBS), or a combination thereof.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: May 30, 2023
    Assignee: Emergex USA Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao, Peter C. Schmidt
  • METHOD OF RAPIDLY ACHIEVING THERAPEUTIC CONCENTRATIONS OF TRIPTANS FOR TREATMENT OF MIGRAINES
    Publication number: 20210275445
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: May 25, 2021
    Publication date: September 9, 2021
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
    Patent number: 11058630
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: July 13, 2021
    Assignee: Zosano Pharma Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • METHOD OF RAPIDLY ACHIEVING THERAPEUTIC CONCENTRATIONS OF TRIPTANS FOR TREATMENT OF MIGRAINES AND CLUSTER HEADACHES
    Publication number: 20200000712
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described.
    Type: Application
    Filed: June 27, 2019
    Publication date: January 2, 2020
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao, Peter C. Schmidt
  • METHOD OF RAPIDLY ACHIEVING THERAPEUTIC CONCENTRATIONS OF TRIPTANS FOR TREATMENT OF MIGRAINES AND CLUSTER HEADACHES
    Publication number: 20190070103
    Abstract: Applicant hereby submits a substitute abstract that is double spaced.
    Type: Application
    Filed: August 23, 2018
    Publication date: March 7, 2019
    Inventors: Mahmoud Ameri, Donald Kellerman, Yi Ao
  • Stable Glucagon Peptide Formulations
    Publication number: 20180153798
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Application
    Filed: October 9, 2017
    Publication date: June 7, 2018
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • METHOD OF RAPIDLY ACHIEVING THERAPEUTIC CONCENTRATIONS OF TRIPTANS FOR TREATMENT OF MIGRAINES
    Publication number: 20180153799
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: January 29, 2018
    Publication date: June 7, 2018
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
    Patent number: 9918932
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: March 20, 2018
    Assignee: Zosano Pharma Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Stable glucagon peptide formulations
    Patent number: 9782344
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: October 10, 2017
    Assignee: ZP OPCO, INC.
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • METHOD OF RAPIDLY ACHIEVING THERAPEUTIC CONCENTRATIONS OF TRIPTANS FOR TREATMENT OF MIGRAINES
    Publication number: 20170239174
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: February 21, 2017
    Publication date: August 24, 2017
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Stable Glucagon Peptide Formulations
    Publication number: 20160051467
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Application
    Filed: November 2, 2015
    Publication date: February 25, 2016
    Inventors: Mahmoud AMERI, Peter E. DADDONA, Yi AO
  • Stable glucagon peptide formulations
    Patent number: 9173924
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: November 3, 2015
    Assignee: ZP OPCO, INC.
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • Stable Glucagon Peptide Formulations
    Publication number: 20150057605
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Application
    Filed: August 22, 2014
    Publication date: February 26, 2015
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • Preservation of bioactive materials by freeze dried foam
    Patent number: 8617576
    Abstract: This invention provides methods, systems and compositions to preserve bioactive materials in a dried foam matrix. Methods provide non-boiling foam generation and penetration of preservative agents at temperatures near the phase transition temperature of the membranes. Bioactive materials can be preserved with high initial viability in a freeze-foam process employing low temperature secondary drying.
    Type: Grant
    Filed: May 6, 2008
    Date of Patent: December 31, 2013
    Assignee: MedImmune, LLC
    Inventors: Reinhard Vehring, Yi Ao
  • PRESERVATION OF BIOACTIVE MATERIALS BY FREEZE DRIED FOAM
    Publication number: 20100297231
    Abstract: This invention provides methods, systems and compositions to preserve bioactive materials in a dried foam matrix. Methods provide non-boiling foam generation and penetration of preservative agents at temperatures near the phase transition temperature of the membranes. Bioactive materials can be preserved with high initial viability in a freeze-foam process employing low temperature secondary drying.
    Type: Application
    Filed: May 6, 2008
    Publication date: November 25, 2010
    Applicant: MEDIMMUNE, LLC
    Inventors: Reinhard Vehring, Yi Ao